Fibrinolysis in the treatment of the amaurosis fugax: A case report;Fibrinolyse dans le traitement de l'amaurosis fugax: À propos d'un cas

Journal Francais d'Ophtalmologie

Volumn 26, Issue 5, 2003, Pages 507-509

  Derieux, L ^a   Guyomard, J L ^a   Catier, A ^a   Derieux, T ^b   Le Callonnec, A ^c   Juveneton, C ^c   Charlin, J F ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b Centre Cardio Pneumologique   (France)

^c NONE   (France)

Author keywords

Amaurosis fugax; Central retinal artery occlusion; Recombinted tissue plasminogen activator

Indexed keywords

ALTEPLASE; ANTITHROMBOCYTIC AGENT;

ADULT; ARTERY EMBOLISM; ARTICLE; CASE REPORT; CENTRAL RETINA ARTERY OCCLUSION; FIBRINOLYSIS; HUMAN; MALE; RECURRENT DISEASE; TRANSITIONAL BLINDNESS;

AMAUROSIS FUGAX; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETINAL VESSELS; TREATMENT OUTCOME;

EID: 0037599584     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Haase CG, Buchner T. Microemboli are not a prerequisite in retinal artery occlusive diseases. Eye, 1998;12:659-62.
2. Palmowski AM, Ruprecht KW. Amaurosis fugax. Fort Med, 1992; 110:531-5.
3. Gazzato G, Torre P. Amaurosis fugax. Riv Neurol, 1981;51:1-26.
4. Burde RM. Amaurosis fugax. J Clin Neuro, 1989;9:1985-9.
5. Dagi LR, Currie J. Branch retinal artery occlusion in the Churg-Strauss syndrome. J Clin Neuro, 1985;5:229-37.
6. Berdel WE, Theiss W, Fink U, Rastetter J. Peripheral arterial occlusion and amaurosis as the first manifestation of polycythemia. A case report. Blut, 1984;48:177-80.
7. Hess DC. Stroke associated with antiphospholipid antibolies. Stroke, 1992;23:123-8.
8. Murata Y, Inada K, Negi A. Susac syndrome. Am J Ophthalmol, 2000;129:682-4.
9. Shimon Rumelt, Yosef Dorenboim, and Uri Rehany, Facs. Agressive Systematic Treatment for Central Retinal Artery Occlusion. Elsev Science Inc, 1999;733-8.
10. Richard G, Lerche RC, Knopse V, Zeumer H. Treatment of retinal arterial occlusion with fibrinolysis recombinant tissue plasminogen activator. Ophthalmology, 1999;106:768-73.
11. Bertram B, Wolf S, Fisches H, Schulte K et al. Thrombolytic treatment of retinal arterial occlusions with plasminogen activator. Klin Mon, 1991;198:295-300.
12. Vulpius K, Hoh H, Lange H et al. Selective percutaneous transluminal thrombolytic therapy with rt-PA in central retinal artery occlusion. Ophthalmology, 1996;93:149-53.
13. P. Annonier, CL. Benichou, J. Flament, A. Bronnier. Place de la fibrinolyse dans le traitement des AOR. Bull Soc Opht, 1988; 1167-71.